Stimulant Abuser Groups to Engage in 12-Step (STAGE-12)

University of Washington

Status and phase: Completed; Phase 3

Conditions: Drug Abuse

Treatments: Behavioral: STAGE-12; Behavioral: Treatment as Usual

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00573183

NIDA-CTN-0031

U10DA013714 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to determine whether a combined group and individual 12-Step facilitative (TSF) intervention, Stimulant Abuser Groups to Engage in 12 -Step (STAGE-12), improves substance -related outcomes.

Full description

This protocol is to evaluate the degree to which a combined group and individual 12-Step facilitative (TSF) intervention, Stimulant Abuser Groups to Engage in 12 -Step (STAGE-12), improves substance -related outcomes compared to treatment as usual (TAU) without STAGE-12 among stimulant abusers. The primary objective is to evaluate reduction in percent of days of stimulant use as measured by self-report. Secondary objectives include evaluating reduction in percent days of use of other substances, the degree to which STAGE-12 increases involvement in 12-step activities and attendance at 12-step meetings, and the extent to which such 12 -step involvement and meeting attendance mediate substance use outcomes.

Enrollment: 471 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• seeking outpatient treatment for stimulant abuse or dependence
• current diagnosis of stimulant abuse or dependence
• willing to participate in the protocol

Exclusion criteria

• not sufficiently medically or psychiatrically stable
• pending legal action that would inhibit their participation in the study
• in need of detoxification from opiates

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

471 participants in 2 patient groups

STAGE-12

Experimental group

Description:

STAGE-12 received 3 individual and 5 group 12-step facilitation sessions focusing on 12-step principles plus an intensive referral in which counselors linked participants to community-based 12-step volunteers. These sessions took the place of 3 individual and 5 group sessions in the standard intensive outpatient drug treatment program and were integrated into treatment as usual.

Treatment:

Behavioral: STAGE-12

Treatment as Usual

Active Comparator group

Description:

Treatment as usual received standard care provided in intensive outpatient drug treatment program without the STAGE-12 components.

Treatment:

Behavioral: Treatment as Usual